[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100587283":3},{"organization":4,"armGroups":7,"interventions":13,"overallOfficials":18,"centralContacts":22,"locations":27,"responsibleParty":42,"collaborators":17,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":49,"acronym":17,"eligibilityCriteria":50,"healthyVolunteers":47,"sex":51,"minAge":52,"maxAge":53,"enrollmentInfo":54,"targetDuration":17,"studyType":57,"phases":58,"briefSummary":60,"conditions":61,"keywords":17,"overallStatus":30,"whyStopped":17,"lastUpdateSubmitDate":72,"lastUpdatePostDateStruct":73,"startDateStruct":76,"completionDateStruct":78,"leadSponsor":80,"locationsCount":81},{"fullName":5,"class":6},"Chinese University of Hong Kong","OTHER",[8],{"label":9,"type":10,"description":9,"interventionNames":11},"Robotic surgery using the Sentire Surgical System","EXPERIMENTAL",[12],"Procedure: Robotic surgery using the Sentire Surgical System",[14],{"type":15,"name":9,"description":9,"armGroupLabels":16,"otherNames":17},"PROCEDURE",[9],null,[19],{"name":20,"affiliation":5,"role":21},"Simon SM Ng, MD","PRINCIPAL_INVESTIGATOR",[23],{"name":20,"role":24,"phone":25,"phoneExt":17,"email":26},"CONTACT","+852-35051495","simonng@surgery.cuhk.edu.hk",[28],{"facility":29,"status":30,"city":31,"state":17,"zip":17,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Prince of Wales Hospital, The Chinese University of Hong Kong","RECRUITING","Hong Kong","China","CN",{"type":35,"coordinates":36},"Point",[37,38],114.17469,22.27832,{"lat":38,"lon":37},[41],{"name":20,"role":24,"phone":25,"phoneExt":17,"email":26},{"type":21,"investigatorFullName":43,"investigatorTitle":44,"investigatorAffiliation":5,"oldNameTitle":17,"oldOrganization":17},"Simon S. M. Ng","Wei Lun Professor of Surgery","100587283","prospective-evaluation-of-cornerstone-robotics-sentire-surgical-system-in-major-gastrointestinal-and-urologic-surgery-100587283",false,"NCT06926374","Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery","General Inclusion Criteria for All Procedures:\n\n* Body mass index \\\u003C35 kg\u002Fm2\n* Suitable for the listed minimally invasive surgical procedures for treatment of respective diseases\n* Willingness to participate as demonstrated by giving informed consent\n\nGeneral Exclusion Criteria for All Procedures:\n\n* Contraindication to general anesthesia\n* Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention\n* Untreated active infection\n* Noncorrectable coagulopathy\n* Presence of another malignancy or distant metastasis\n* Emergency surgery\n* Vulnerable population (e.g., mentally disabled, pregnancy)\n\nRobotic Colorectal Resection\n\nInclusion Criteria:\n\n\\- Adenocarcinoma or large adenoma (not amenable to endoscopic removal) located at the colorectum (from the cecum to the anal verge) amenable to minimally invasive surgery\n\nExclusion Criteria:\n\n* T4 tumor\n* Recurrent tumor\n* Extensive previous abdominal surgery precluding minimally invasive surgery\n\nRobotic Transanal Total Mesorectal Excision\n\nInclusion Criteria:\n\n\\- Mid\u002Flow rectal adenocarcinoma located \\\u003C12 cm from the anal verge\n\nExclusion Criteria:\n\n* T4 tumor or involvement of circumferential resection margin even after neoadjuvant therapy\n* Tumor requiring multivisceral resection\n* Tumor requiring abdominoperineal resection; recurrent rectal tumor\n* T1 tumor that can be treated by local excision\n* Extensive previous abdominal surgery\n\nRobotic Rectopexy\n\nInclusion Criteria:\n\n* Clinically diagnosed with previously untreated and uncomplicated rectal prolapse or enterocele\n\nExclusion Criteria:\n\n\\- Extensive previous abdominal surgery precluding minimally invasive surgery\n\nRadical Prostatectomy\n\nInclusion Criteria:\n\n\\- Clinically diagnosed with nonmetastatic adenocarcinoma of prostate\n\nExclusion Criteria:\n\n\\- Previous history of prostate surgery (e.g., transurethral resection of prostate)\n\nTotal or Partial Nephrectomy\n\nInclusion Criteria:\n\n\\- Clinically diagnosed with nonmetastatic kidney cancer\n\nExclusion Criteria:\n\n* Previous ipsilateral kidney surgery\n* Complex kidney anatomy (e.g., horseshoe kidney, complex renal vascular anatomy)\n\nRadical Cystectomy\n\nInclusion Criteria:\n\n\\- Clinically diagnosed with nonmetastatic bladder cancer\n\nRobotic Esophageal Hiatal Surgery and Fundoplication\n\nInclusion Criteria:\n\n\\- Clinically diagnosed with Hiatal Hernia and \u002F or Gastroesophageal reflux disease amendable to fundoplication\n\nExclusion Criteria:\n\n\\- Previous history of laparotomy precluding minimally invasive surgery\n\nRobotic Gastrectomy\n\nInclusion Criteria:\n\n\\- Clinical diagnosis of gastric tumor (Adenocarcinoma or Gastrointestinal Stromal Tumor (GIST)) amendable to minimally invasive radical gastrectomy\n\nExclusion Criteria:\n\n\\- Previous history of laparotomy precluding minimally invasive surgery\n\nRobotic Esophagectomy\n\nInclusion Criteria:\n\n\\- Clinical diagnosis of carcinoma of esophagus amendable to minimally invasive esophagectomy\n\nExclusion Criteria:\n\n\\- Esophageal carcinoma after definitive chemoradiotherapy and indicated for salvage esophagectomy\n\nRobotic Cholecystectomy\n\nInclusion Criteria:\n\n\\- Symptomatic gallbladder stones clinically indicated for laparoscopic cholecystectomy\n\nExclusion Criteria:\n\n* Acute cholecystitis\n* Previous history of abdominal surgery","ALL","18 Years","80 Years",{"count":55,"type":56},90,"ESTIMATED","INTERVENTIONAL",[59],"NA","Robotic assisted surgery has been performed for more than two decades with good success and safety profile. However, there was only one dominating robotic surgical system available in the past which led to high cost for robotic surgery. Recently, a new robotic surgical system (Sentire Robotic Surgical System) was introduced by researchers of The Chinese University of Hong Kong (CUHK). This new robotic surgical system aims to achieve similar outcomes and standards of robotic surgery performed using the dominating system but with a significantly lower cost. The technologic innovation and development of this new robotic system is made by the Cornerstone Robotics Limited, which is based in Hong Kong. In a pilot clinical study conducted at Prince of Wales Hospital involving 55 patients, the Sentire Robotic Surgical System had demonstrated high success rate with minimal complications in patients who underwent robotic colorectal, upper gastrointestinal, and urologic surgery. Researchers of CUHK would therefore like to conduct another prospective study to further evaluate the efficacy and safety of Sentire Surgical System C1000 in major gastrointestinal and urologic surgery with expanded indications. It is believed that the results of this study will provide data to support its use for wide range of procedures with minimal access trauma, for the benefit of patients. This system will also lead to a wider range of clinical application for minimally invasive surgery with a cost-effective model.",[62,63,64,65,66,67,68,69,70,71],"Colorectal Carcinoma","Rectal Prolapse","Prostate Cancer (Adenocarcinoma)","Bladder Cancer","Kidney Cancer","Hiatal Hernia With Gastroesophageal Reflux Disease","GIST - Gastrointestinal Stromal Tumor","Esophageal Cancer","Gallstones","Gastric Cancer","2025-04-11",{"date":74,"type":75},"2025-04-16","ACTUAL",{"date":77,"type":75},"2025-03-25",{"date":79,"type":56},"2027-04",{"name":5,"class":6},1]